| Original language | English |
|---|---|
| Pages (from-to) | 1016-1018 |
| Number of pages | 3 |
| Journal | American Journal of Hematology |
| Volume | 99 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Jun 2024 |
ASJC Scopus Subject Areas
- Hematology
Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?
- Jeremy W. Jacobs
- , Laura D. Stephens
- , David M. Chooljian
- , Deva Sharma
- , Brian D. Adkins
- , Garrett S. Booth
Research output: Contribution to journal › Comment/debate › peer-review